CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
News Jan 30, 2009
CombinatoRx, Incorporated has announced the publication of new in vivo research in Arthritis Research and Therapy on a systems biology based strategy that selectively amplifies the anti-inflammatory activity of very low dose glucocorticoids in immune cells without modulation of pathways associated with glucocorticoid toxicity.
This research, which was conducted by CombinatoRx scientists, demonstrates that the multi-target mechanism of low dose prednisolone (a glucocorticoid) combined with dipyridamole (a cardiovascular agent) creates a dissociated activity profile with an increased therapeutic window through selective amplification of glucocorticoid-mediated anti-inflammatory signaling.
The combination suppressed release of pro-inflammatory mediators, including TNF-a, IL-6 and others, from human peripheral blood mononuclear cells and mouse macrophages. After 8 weeks of oral dosing in mouse models, the immune-specific amplification of prednisolone’s anti-inflammatory activity by dipyridamole did not extend to glucocorticoid-mediated adverse effects including corticosterone suppression.
“This research demonstrates the utility of a systems biology approach to identifying novel therapeutics that are pathway, or multi-target, focused,” said Alexis Borisy, President and CEO of CombinatoRx. “Earlier attempts by the pharmaceutical industry at steroid dissociation using medicinal chemistry have shown mixed results because the anti-inflammatory activity and adverse effects of glucocorticoids do not break cleanly along mechanistic lines of transcription activation and repression. The systems biology approach leverages multi-target action to amplify glucocorticoid activity selectively within the unique network context of inflammatory cells, rather than attempting to dissect various aspects of glucocorticoid receptor biology.”
New Studies Demonstrate Risk Reduction Potential of Heat-Not-Burn Tobacco Products and e-CigarettesNews
Data presented at the Society of Toxicology Annual Meeting (SOT) have demonstrated the potential of two different heat-not-burn tobacco products and e-cigarettes to reduce the risk of smoking-related diseases, in comparison to continued use of conventional cigarettes.READ MORE
Low Temperatures Turn Stem Cells into Calorie-Burning FatNews
The secret to healthy eating may not be in freezer food, but low temperatures can help turn stem cells into brown fat, a type of fat which helps burn calories. A new study could turn this knowledge into weight-loss treatments.READ MORE
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE